Literature DB >> 21273778

The prevalence of long spinal cord lesions and anti-aquaporin 4 antibodies in neuromyelitis optica patients in Taiwan.

Kai-Chen Wang1, Ching-Piao Tsai, Chao-Lin Lee, Shao-Yuan Chen, Shyi-Jou Chen.   

Abstract

BACKGROUND AND
OBJECTIVE: It was the aim of this study to determine the prevalence of anti-aquaporin 4 antibody (anti-AQP4 Ab) and long spinal cord lesions in neuromyelitis optica (NMO) and multiple sclerosis (MS) patients in Taiwan. Asia has a relatively high rate of NMO compared with MS patients. Anti-AQP4 Ab is an important marker for NMO worldwide, but serological data and clinical profiles of NMO patients in Taiwan have not been reported.
METHODS: This retrospective study compared the clinical symptoms, demographics, spinal cord lesion length and AQP4 Ab status of 34 patients with NMO with 34 patients diagnosed with conventional MS.
RESULTS: Our NMO patients were predominantly middle-aged women (median age 45 years), exhibited many relapses (1.0/year) and displayed a higher Expanded Disability Status Scale score (4.75) than conventional MS patients. NMO patients exhibited long spinal cord lesions as detected by MRI. Forty-one percent of the NMO patients had detectable anti-AQP4 Ab. The Expanded Disability Status Scale score was significantly higher in AQP4 Ab- NMO patients.
CONCLUSION: The prevalence of AQP4 Ab in a Taiwanese NMO group was 41%. Long spinal cord lesions and detection of AQP4 Ab helped to differentiate NMO patients from MS patients. Long spinal cord lesions with the anti-AQP4 Ab test may allow for an earlier diagnosis of NMO and improve therapeutic decisions.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21273778     DOI: 10.1159/000322740

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  5 in total

Review 1.  Magnetic resonance imaging in neuromyelitis optica spectrum disorder.

Authors:  Laura Clarke; Simon Arnett; Kate Lilley; Jacky Liao; Sandeep Bhuta; Simon A Broadley
Journal:  Clin Exp Immunol       Date:  2021-07-06       Impact factor: 4.330

2.  The frequency of anti-aquaporin-4 Ig g antibody in neuromyelitis optica and its spectrum disorders at a single tertiary referral center in malaysia.

Authors:  Shanthi Viswanathan; Masita Arip; Norhazlin Mustafa; Jasbir S Dhaliwal; Norzainie Rose; Sobri Muda; Santhi Datuk Puvanarajah; Mohammad Hanip Rafia; Mark Cheong Wing Loong
Journal:  Mult Scler Int       Date:  2014-11-17

3.  A comparison between spinal cord infarction and neuromyelitis optica spectrum disorders: Clinical and MRI studies.

Authors:  Jung Lung Hsu; Mei-Yun Cheng; Ming-Feng Liao; Hui-Ching Hsu; Yi-Ching Weng; Kuo-Hsuan Chang; Hong-Shiu Chang; Hung-Chou Kuo; Chin-Chang Huang; Rong-Kuo Lyu; Kun-Ju Lin; Long-Sun Ro
Journal:  Sci Rep       Date:  2019-05-15       Impact factor: 4.379

4.  Correlations among disability, anti-AQP4 antibody status and prognosis in the spinal cord involved patients with NMOSD.

Authors:  Jung Lung Hsu; Ming-Feng Liao; Kuo-Hsuan Chang; Mei-Yun Cheng; Long-Sun Ro
Journal:  BMC Neurol       Date:  2021-04-09       Impact factor: 2.474

5.  Poor responses to interferon-beta treatment in patients with neuromyelitis optica and multiple sclerosis with long spinal cord lesions.

Authors:  Kai-Chen Wang; Kuan-Hsiang Lin; Tzu-Chi Lee; Chao-Lin Lee; Shao-Yuan Chen; Shyi-Jou Chen; Li-Te Chin; Ching-Piao Tsai
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.